Filing Details
INTELLIGENT BIO SOLUTIONS INC. (NASDAQ:INBS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 10, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:INBS
INTELLIGENT BIO SOLUTIONS INC. (INBS) Files Quarterly Report for Q0
INTELLIGENT BIO SOLUTIONS INC. (NASDAQ:INBS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 10, 2026.
At publication ·
What changed
INTELLIGENT BIO SOLUTIONS INC. (NASDAQ:INBS) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Intelligent Bio Solutions Inc. (NASDAQ: INBS) filed its quarterly report on November 10, 2026, as required by the SEC.
- The company's stock trades at $2.29 with a market capitalization of $4.7 million.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance and conditions.
Market Context
INTELLIGENT BIO SOLUTIONS INC.'s stock currently trades at $2.29 with a market capitalization of $4.7M.
The 10-Q provides INTELLIGENT BIO SOLUTIONS INC.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for INTELLIGENT BIO SOLUTIONS INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View INBS Stock Page
Frequently Asked Questions
Where can I read INBS's SEC filings?
Browse all filings on our INBS SEC filings page.
What types of SEC filings does INTELLIGENT BIO SOLUTIONS INC. file?
Public companies like INTELLIGENT BIO SOLUTIONS INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.